These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 2848895

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human B cell activation: selective sensitivity of the early stages to calcium channel-blocking drugs.
    Dugas B, Vazquez A, Delfraissy JF, Gérard JP, Rannou MT, Galanaud P.
    Eur J Immunol; 1986 Feb; 16(2):162-7. PubMed ID: 2420605
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early events in human B cell activation: metabolic pathways vary according to the first signal used.
    Dugas B, Vazquez A, Klein B, Delfraissy JF, Rammou M, Gerard JP, Galanaud P.
    Eur J Immunol; 1986 Dec; 16(12):1609-14. PubMed ID: 3028818
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
    Daibata M, Humphreys RE, Takada K, Sairenji T.
    J Immunol; 1990 Jun 15; 144(12):4788-93. PubMed ID: 2161880
    [Abstract] [Full Text] [Related]

  • 7. Cross-linkage of Ly-6A/E induces Ca2+ translocation in the absence of phosphatidylinositol turnover and mediates proliferation of normal murine B lymphocytes.
    Snapper CM, Yamada H, Mond JJ, June CH.
    J Immunol; 1991 Aug 15; 147(4):1171-9. PubMed ID: 1907991
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
    Chen C, Johnston TD, Jeon H, Gedaly R, McHugh P, Ranjan D.
    J Surg Res; 2009 May 01; 153(1):156-61. PubMed ID: 18486150
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
    Francois DT, Katona IM, June CH, Wahl LM, Feuerstein N, Huang KP, Mond JJ.
    J Immunol; 1988 May 15; 140(10):3338-43. PubMed ID: 3129493
    [Abstract] [Full Text] [Related]

  • 11. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G, Ehlin-Henriksson B, Schlossman SF.
    J Immunol; 1983 Apr 15; 130(4):1985-9. PubMed ID: 6300235
    [Abstract] [Full Text] [Related]

  • 12. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
    Masucci MG, Szigeti R, Ernberg I, Hu CP, Torsteinsdottir S, Frade R, Klein E.
    Eur J Immunol; 1987 Jun 15; 17(6):815-20. PubMed ID: 3036539
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
    Maly FE, Cross AR, Jones OT, Wolf-Vorbeck G, Walker C, Dahinden CA, De Weck AL.
    J Immunol; 1988 Apr 01; 140(7):2334-9. PubMed ID: 2832475
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG, Kulas DT, Way BA, Mooney RA.
    Cancer Res; 1994 Jun 15; 54(12):3179-85. PubMed ID: 8205537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C, Zubler RH.
    J Immunol; 1989 Jan 01; 142(1):87-93. PubMed ID: 2535862
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.